Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114730) titled 'A Prospective Randomized Controlled Study on Adjuvant Transarterial Chemoembolization (TACE) Before and After Surgery for Long-term Prognosis in Patients with Multinodular Hepatocellular Carcinoma' on Dec. 17, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: West China Hospital, Sichuan University
Condition:
hepatocellular carcinoma
Intervention:
Control group:Postoperative TACE (treatment)
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2026-01-01
Target Sample Size: Control group:78;Test group:78;
Countries of Recruitment:
China
To know more, ...